Human CD272 Protein, Fc Tag
- 
									
产品编号
KMP2384
 - 
									
别名
B和T淋巴细胞衰减因子, B- and T-Lymphocyte Attenuator, CD272
 - 
									
规格
- 50ug
 - 100ug
 - 200ug
 
 
| Catalog Number | KMP2384 | 
| Alias | B和T淋巴细胞衰减因子, B- and T-Lymphocyte Attenuator, CD272 | 
| Size | 50ug, 100ug, 200ug | 
| Product Description | The Human CD272 Protein(KMP2384) is produced in HEK293 Cells and the target gene encoding Lys31-Leu150 is expressed with a Fc tag at the C-terminus. | 
| Molecular Name | CD272 | 
| Product Introduction | CD272(BTLA):免疫球蛋白超家族(IgSF)成员,通过跨膜形式参与T细胞活化的负向调控。 | 
| Molecular Weight | 13.2 kDa | 
| Expression System | HEK293 Cells | 
| Species | Human | 
| Purity | >90% | 
| SDS-PAGE | ![]()  | 
| Purification | Affinity Purification | 
| Uniprot ID | L8EAT9#sequences | 
| Storage Condition | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. | 
| Formulation | 20mM PB, 150mM NaCl, pH7.4 | 
| Shipping Condition | In general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form. | 
| Background | B- and T-Lymphocyte Attenuator(BTLA) is a single-pass type I membrane protein containing 1 Ig-like V-type(immunoglobulin-like) domain. BTLA expression is induced during activation of T cells, and BTLA remains expressed on Th1 cells but not Th2 cells. Like PD1 and CTLA4, BTLA interacts with a B7 homolog, B7H4. However, unlike PD-1 and CTLA-4, BTLA displays T-Cell inhibition via interaction with tumor necrosis family receptors(TNF-R), not just the B7 family of cell surface receptors. BTLA is a lymphocyte inhibitory receptor that inhibits lymphocytes during immune response. BTLA also is a ligand for tumor necrosis factor(receptor) superfamily, member 14(TNFRSF14), also known as herpes virus entry mediator(HVEM). BTLA-HVEM complexes negatively regulate T-cell immune responses. | 
| Endotoxin | <1.0 EU/ug determined by the LAL method | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
蛋白可以在-80°C下储存以便长期保存。应分装并避免冻融循环,以保持蛋白的稳定性。
可以通过优化质粒设计、使用高效转染试剂、优化细胞培养条件以及使用蛋白折叠伴侣或密码子优化来提高蛋白表达效率。
							
							
							
							
						
								0